During the past decade, Spotlight research center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spotlight research center" are "Hot Flashes" (2 trials), "Atopic Dermatitis" (1 trials), "Diabetic Neuropathy Peripheral" (1 trials) and "Respiratory Syncytial Virus" (1 trials). Many other conditions were trialed in "Spotlight research center" in a lesser frequency.

Most popular intervention types in "Spotlight research center" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "fezolinetant" (2 trials), "placebo" (2 trials), "Active Provant Therapy System" (1 trials) and "Inactive (sham) Provant Therapy System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spotlight research center" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Spotlight research center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Spotlight research center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spotlight research center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".